Fluorinated gases in medical chillers: what changes for hospitals and manufacturers in 2026

Key data

Operators and manufacturers of fixed medical chillers that depend on fluorinated greenhouse gases (F-gas) to preserve medicines, vaccines and other temperature-sensitive products have received temporary approval from the European Union. The Commission Implementing Regulation (EU) 2026/2491, published on 11 November 2026 and in force since the previous day, grants a specific exemption from the general framework of Regulation (EU) 2024/573 on F-gas.

The key to this decision is technical and economic: the European Commission recognizes that, to date, there are no viable alternatives for these devices in the healthcare environment. But the exemption is not a blank check: it has an implicit expiration date and requires strict compliance in traceability and reporting.

What does this regulation establish?

Regulation (EU) 2024/573 is the European framework that regulates and progressively restricts the use of fluorinated greenhouse gases, with the aim of reducing their climate impact. These gases are widely used in refrigeration and air conditioning systems, but their global warming potential is very high.

The new Commission Implementing Regulation (EU) 2026/2491 introduces a specific exemption for a very specific segment: fixed chillers for medical application. The official justification is the non-existence of technically or economically viable alternatives for these devices in the healthcare sector.

The exemption does not eliminate the traceability and reporting obligations established in the current F-gas regulations. Affected companies must properly document the use of these gases to comply with monitoring and notification requirements.

Economic and operational impact

For operators of healthcare facilities and manufacturers of medical equipment, this exemption has a direct and positive economic impact in the short term: it avoids the need to replace or convert medical refrigeration equipment that still has no viable technological alternative.

However, the operational impact is not neutral. Affected companies must assume two types of burden:

• Documentary compliance burden: Maintain updated records of F-gas use in these devices, with complete traceability according to Regulation (EU) 2024/573.
• Risk of future review: The exemption is temporary. As technological alternatives advance, the Commission may withdraw it. Companies that have not initiated technological transition will be exposed to higher adaptation costs.

The cost of failing to properly document F-gas use can result in breaches of general regulations, with the sanctioning consequences that this entails under the framework of Regulation (EU) 2024/573.

Who does it affect?

• Public and private hospitals that operate fixed medical chillers for the preservation of medicines, vaccines or other temperature-sensitive products.
• Clinics and healthcare facilities with medical refrigeration equipment that use fluorinated gases.
• Manufacturers of fixed chillers for medical use that market or install these devices in the European market.
• Maintenance and technical service companies for refrigeration equipment in the healthcare sector, responsible for the management and refilling of F-gas.
• Procurement and facility management managers in large hospital centers that manage maintenance contracts for these devices.

Practical example

A medium-sized hospital operates several fixed medical chillers to preserve vaccines and oncology medicines at controlled temperature. Under Regulation (EU) 2024/573, the use of F-gas in these devices would be subject to progressive restrictions that could force costly technological replacement and, at this time, with no viable technical alternative on the market.

Thanks to Commission Implementing Regulation (EU) 2026/2491, that hospital can continue operating its medical chillers with F-gas without breaching European regulations, provided that:

1. It documents the type and quantity of F-gas used in each device.
2. It maintains the traceability records required by Regulation (EU) 2024/573.
3. It reports the use in accordance with the deadlines and formats established in the current F-gas regulations.

If the hospital does not maintain that documentation, the exemption does not protect it against an inspection: documentary non-compliance is independent of the authorization to use.

What should companies do now?

1. Verify if their equipment is covered by the exemption: Confirm that the operated chillers are fixed chillers for medical use within the meaning of Regulation (EU) 2026/2491. Not all refrigeration equipment in healthcare environments is automatically included.
2. Review and update the F-gas documentation system: Ensure that records of use, refilling and maintenance of fluorinated gases comply with the traceability requirements of Regulation (EU) 2024/573. The exemption does not exempt from these obligations.
3. Establish a reporting protocol: Designate an internal manager responsible for monitoring and reporting F-gas use in medical equipment, in accordance with the deadlines established in current regulations.
4. Monitor the review of the exemption: The exemption is temporary. Track communications from the European Commission on the progress of technological alternatives to anticipate when the exemption may be withdrawn.
5. Begin evaluation of technological alternatives: Although the exemption is in force, begin exploring what F-gas-free technological options are emerging on the market, to avoid being exposed to a forced and costly transition when the exemption expires.

Official source

Consult the complete regulation in official source

Notice: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602491